Hudson Value Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-7,425
Closed -$947K 108
2022
Q4
$947K Buy
7,425
+75
+1% +$8.7K 0.58% 52
2022
Q3
$768K Sell
7,350
-50
-0.7% -$5.49K 0.52% 57
2022
Q2
$777K Sell
7,400
-3,055
-29% -$362K 0.49% 55
2022
Q1
$1.34M Buy
10,455
+485
+5% +$58.5K 0.69% 44
2021
Q4
$1.23M Buy
9,970
+2,750
+38% +$360K 0.6% 53
2021
Q3
$1.03M Buy
7,220
+597
+9% +$87.8K 0.56% 59
2021
Q2
$1.03M Sell
6,623
-17
-0.3% -$2.75K 0.57% 60
2021
Q1
$1.03M Buy
6,640
+4
+0.1% +$620 0.62% 54
2020
Q4
$981K Buy
+6,636
New +$937K 0.66% 49

Other funds holding ZBH

Hudson Value Partners's ZBH Position: Q1 2023 in Review

Hudson Value Partners sold out of Zimmer Biomet (ZBH) in Q1 2023, closing a stake of 7,425 shares — an estimated $947K sold.

Hudson Value Partners first reported a position in ZBH in Q4 2020 and held it in 9 quarters. The position peaked at $1.34M in Q1 2022. 993 funds tracked by Wall St. Rank hold ZBH as of Q1 2023.

  • Hudson Value Partners reported no remaining Zimmer Biomet position as of Q1 2023 after selling out during the quarter.
  • Hudson Value Partners sold 7,425 Zimmer Biomet shares in Q1 2023, an estimated $947K.
  • Hudson Value Partners first reported a position in Zimmer Biomet in Q4 2020 and held it in 9 quarters.
  • Hudson Value Partners's Zimmer Biomet position peaked at $1.34M in Q1 2022.
  • 993 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2023.

Based on Hudson Value Partners's 13F filing for Q1 2023, filed 9 May 2023.